Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)
Status:
Active, not recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of intra-tendon injection of
allogeneic adipose-derived mesenchymal stem cells (Allo-ASC) in intractable common extensor
tendinosis patients in comparison with a control treatment.